SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotech Short Candidates
An SI Board Since December 2000
Posts SubjectMarks Bans
897 95 0
Emcee:  tuck Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
297Dang, slept late this morning and missed my shot at AGEN. It appears to be off tuck-1/8/2003
296Tuck >>Neither of those two back-up vaccines involve QS-21 or other AGEN Icebrg-1/8/2003
295Hi, Erik, I wasn't saying Elan's entire Alzheimer's immunotherapy ptuck-1/7/2003
294>>One is AN-1792, Elan's Alzheimer's immunotherapy that caused CNSIcebrg-1/7/2003
293I have to give AGEN credit for a well timed secondary, some 4 million shares fortuck-1/7/2003
292Starting to dig into AGEN. Very little interest on SI. You've mentioned ittuck-1/7/2003
291>>VXGN is on the UPC11830 list, so I wouldn't know how you would mirrotuck-1/7/2003
290The only problem with this move is that VXGN is on the UPC11830 list, so I wouldLondo-1/1/2003
289The VaxGen short is basically a bet against efficacy of its AIDSVAX B/B vaccine tuck-12/31/2002
288BSCP, in a daring mood, shorts a half position of VXGN. More of a trade on techtuck-12/31/2002
287BSCP closes it GMXX position at $5.80, the current ask. Almost 40% in less thantuck-12/30/2002
286Thanks for the acknowledgment, Tuck. I also feel that 03 will be a better year fSpekulatius-12/20/2002
285Well, folks, it's been a year since I attached a portfolio this thread and stuck-12/20/2002
284Adding VXGN and AGEN, both developers of vaccines, to the Watchlist. VXGN has btuck-12/17/2002
283Tuck, I draw a blank. Wouldn't reversion to the mean predict I'd be wrkeokalani'nui-12/13/2002
282Wilder, Nice pointer here at GNTA. It may yet come through, but has been chopptuck-12/13/2002
281BSCP covers ABI short at $17.9. It is down hard on news that WAT lowered guidantuck-12/13/2002
280Boy, was I early. Not sure why ALKS is down to the low $7s on good volume and ntuck-12/10/2002
279BSCP covers ALKS @ $7.95 for ~11% in two weeks. Might be early. I would not extuck-12/9/2002
278Voluntary disclosure time: BSCP manager just got filled on some CHIR puts. BSCtuck-12/9/2002
277Was thinking of Stefaan's strategy -- got mixed up (again). fredfred hayes-12/6/2002
276Strategy? Don't really have one for CEPH. I've been aware of the possituck-12/6/2002
275Tuck, I read this as a bad sign for your strategy. It may mean that the expectatfred hayes-12/6/2002
274From Briefing.com >>12:03PM Cephalon: put buying seen ahead of Provigil dtuck-12/6/2002
273BSC takes a starter position in CHIR. 240 shares at $40.25. Position based mortuck-12/6/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News